Trellis Bioscience, LLC
Redwood City, CA, US· latest recorded location
Trellis Bioscience, LLC is named on 29 US grants and 38 published applications in this corpus. Its most frequent classification is C07K (Peptides).
- Granted patents
- 29
- Published applications
- 38
- Inventors
- 34
- Granted in 2026 so far
- 1
- Most recent grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 0 | 1 |
| 2002 | 2 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 2 | 2 |
| 2006 | 1 | 0 |
| 2007 | 1 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 2 |
| 2010 | 1 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 2 |
| 2013 | 1 | 1 |
| 2014 | 1 | 2 |
| 2015 | 1 | 4 |
| 2016 | 1 | 1 |
| 2017 | 1 | 2 |
| 2018 | 1 | 2 |
| 2019 | 1 | 2 |
| 2020 | 5 | 2 |
| 2021 | 1 | 3 |
| 2022 | 2 | 3 |
| 2023 | 1 | 0 |
| 2024 | 1 | 4 |
| 2025 | 2 | 1 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 67 documents
- C07KPeptides50
- A61KMedicines and medical preparations40
- A61PTherapeutic uses of medicines40
- G01NInvestigating or analysing materials by determining their chemical or physical properties27
- C12NMicroorganisms or enzymes19
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms11
- Y10TTechnical subjects covered by former us classification6
- C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms4
- C40BCombinatorial chemistry4
- Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4
Recent patents
- Therapeutic protein formulations comprising anti-DNABII antibodies and uses thereof2 Jun 2026US 12,643,941 B2
- Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof9 Dec 2025US 12,491,245 B2
- Immunogen providing an extended protective lifetime against respiratory syncytial virus (RSV) and vaccines thereof11 Mar 2025US 12,246,063 B2
- Binding moieties for biofilm remediation26 Nov 2024US 12,152,068 B2
- Conformational epitopes in respiratory syncytial virus G protein central conserved region3 Oct 2023US 11,773,143 B2
- Rsv passive and active vaccines19 Jun 2025US 2025/0195636 A1
- Anti-alk antibodies and uses thereof1 Aug 2024US 2024/0254258 A1
- Diagnostics for Emerging Disease11 Jul 2024US 2024/0226877 A9
- Conformational epitopes in respiratory syncytial virus g protein central conserved region9 May 2024US 2024/0150414 A1
- Diagnostics for Emerging Disease25 Apr 2024US 2024/0131508 A1
Most cited
By later US patents
- Use of particulate labels in bioanalyte detection methods51US 7,413,868 B22008
- Method to assess library X library interactions21US 6,492,125 B22002
- High throughput microscopy16US 6,444,992 B12002
- Use of particulate labels in bioanalyte detection methods16US 7,939,344 B22011
- Binding moieties for biofilm remediation15US 10,233,234 B22019